MCM
REGN icon

Manchester Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Manchester Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.5K Buy
46
+3
+7% +$2.3K 0.01% 555
2025
Q4 		$33.2K Sell
43
-225
-84% -$153K ﹤0.01% 567
2025
Q3 		$151K Sell
268
-16
-6% -$9.05K 0.02% 357
2025
Q2 		$149K Buy
284
+61
+27% +$34K 0.02% 391
2025
Q1 		$141K Buy
223
+62
+39% +$42.6K 0.02% 379
2024
Q4 		$115K Buy
161
+18
+13% +$15.1K 0.01% 417
2024
Q3 		$150K Hold
143
– – 0.02% 378
2024
Q2 		$150K Buy
143
+69
+93% +$66.9K 0.02% 358
2024
Q1 		$71.2K Buy
74
+9
+14% +$8.56K 0.01% 435
2023
Q4 		$57.1K Buy
65
+10
+18% +$8.23K 0.01% 419
2023
Q3 		$45.3K Hold
55
– – 0.01% 431
2023
Q2 		$39.5K Buy
55
+13
+31% +$10K 0.01% 434
2023
Q1 		$34.5K Buy
42
+37
+740% +$27.9K ﹤0.01% 456
2022
Q4 		$3.61K Buy
+5
New +$3.69K ﹤0.01% 586
2021
Q1 		– Sell
-3
Closed -$1K – 756
2020
Q4 		$1K Buy
+3
New +$1.62K ﹤0.01% 685
2015
Q1 		– Sell
-35
Closed -$14K – 799
2014
Q4 		$14K Buy
35
+14
+67% +$5.51K ﹤0.01% 930
2014
Q3 		$8K Hold
21
– – ﹤0.01% 977
2014
Q2 		$6K Hold
21
– – ﹤0.01% 1005
2014
Q1 		$6K Sell
21
-11
-34% -$3.39K ﹤0.01% 906
2013
Q4 		$9K Sell
32
-400
-93% -$115K ﹤0.01% 803
2013
Q3 		$135K Sell
432
-339
-44% -$89.2K 0.02% 410
2013
Q2 		$173K Buy
+771
New +$180K 0.03% 338

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Manchester Capital Management's REGN Position: Q1 2026 in Review

Manchester Capital Management increased its Regeneron Pharmaceuticals (REGN) stake by 7% in Q1 2026, buying an estimated $2.3K and bringing the position to 46 shares worth $35.5K. The position accounts for 0.01% of the portfolio, ranked #555.

Manchester Capital Management first reported a position in REGN in Q2 2013 and has held it in 22 quarters since. The position peaked at $173K in Q2 2013. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Manchester Capital Management held 46 shares of Regeneron Pharmaceuticals worth $35.5K as of Q1 2026.
  • Manchester Capital Management bought 3 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $2.3K.
  • Regeneron Pharmaceuticals made up 0.01% of Manchester Capital Management's portfolio in Q1 2026, its #555 holding.
  • Manchester Capital Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 22 quarters since.
  • Manchester Capital Management's Regeneron Pharmaceuticals position peaked at $173K in Q2 2013.
  • 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.